Manager TitleAgeSince
Chief Executive Officer 86 2013-08-31
Director of Finance/CFO 55 2012-09-30
Director TitleAgeSince
Chairman 54 2021-08-11
Director/Board Member 45 -
Director/Board Member 54 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-38.68% - - 106K
+0.99%+0.35%+4.91%+16.06% 48.7B
+3.71%+6.75%+459.45%+557.32% 42.05B
+2.70%+0.38%+34.49%+10.04% 38.26B
+5.60%+8.13%+16.67%+72.18% 37.5B
+2.21%+4.89%+17.24%+51.64% 31.44B
+2.23%+1.73% - - 16.47B
+0.97%+2.14%+37.25%+128.28% 16.33B
-0.11%+1.75%+8.05%+18.47% 13.98B
+0.75%+14.01%+77.94%+29.28% 12.68B
Average +1.94%+3.06%+82.00%+110.41% 28.6B
Weighted average by Cap. +2.58%+2.31%+98.60%+131.40%

Financials

2020 2021
Net sales 1.5M 1.74M 1.4M 1.29M 2.42M 165M 2.46M 16.46M 6.46M 82.85M 6.52M 6.38M 274M 1.08M 1.25M 1.01M 923K 1.74M 119M 1.76M 11.8M 4.63M 59.4M 4.68M 4.57M 196M
Net income 14.75M 17.05M 13.77M 12.63M 23.76M 1.62B 24.14M 162M 63.42M 813M 64.02M 62.62M 2.69B -10.57M -12.22M -9.87M -9.06M -17.04M -1.16B -17.31M -116M -45.47M -583M -45.91M -44.9M -1.93B
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33